$SNTI Cashflow Statement | Understand Stock

$SNTI

$0.18 -$0.01 (7.06%) Close

$SNTI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 10 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
Interest and dividend income on investments held in Trust Account
Prepaid expenses
Accounts payable and other current liabilities
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Loss on write-off of fixed assets
Interest income accrued and not received
Issuance of common stock for Common Stock Purchase Agreement fee
Depreciation
Amortization of operating lease right-of-use assets
Accretion of discount on short-term investments
Gain on extinguishment of convertible notes
Gain on disposal of business
Impairment of long-lived assets
Change in fair value
Change in fair value of GeneFab Note Receivable - related party
Change in fair value of GeneFab Economic Share - related party
GeneFab Option
Change in fair value of Preferred Stock Tranche liability - related party
Change in fair value of contingent earnout liability
Other non-cash charges

Changes in operating assets and liabilities:
Accounts receivable
Nonrelated Party
Related Party
Total accounts receivable

Prepaid expenses and other assets
Nonrelated Party
Related Party
Total prepaid expenses and other assets

Operating lease right-of-use assets
Accounts payable
Accrued expenses and other current liabilities
Franchise tax payable
Operating lease liabilities
GeneFab sublease deferred income - related party
Deferred revenue
Deferred revenue, current - related party
Other non-current liabilities

Net cash used in operating activities

CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of short-term investments
Maturity of short-term investments
Purchases of property and equipment
Proceeds from sale of property and equipment
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from promissory note—related party
Repayment of promissory note—related party
Proceeds from initial public offering, net of underwriting discount paid
Proceeds from Merger and related PIPE financing, net of transaction costs
Proceeds from issuance of common stock
2025 ATM Agreement
Common Stock Purchase Agreement
Total proceeds from issuance of common stock
Proceeds from issuance of common stock under Employee Stock Purchase Plan (ESPP)
Proceeds from issuance of convertible notes
Proceeds from issuance of Series B redeemable convertible preferred stock, net of issuance costs
Principal finance lease payments
Proceeds from CIRM Grant
Payment of issuance costs
Proceeds from private placement, net of fees paid to investor
Net cash provided by financing activities

Net Change in Cash
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — Beginning of period
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — End of period
Cash and cash equivalents
Restricted cash
SUPPLEMENTAL DISCLOSURES OF NONCASH FINANCING AND INVESTING ITEMS:
Remeasurement of Class A common stock subject to redemption to redemption value
Deferred underwriting fee payable
Offering costs paid in exchange for issuance of Class B common stock to Sponsor
Waiver of deferred underwriting commissions by underwriter
Purchase of property and equipment in accounts payable and accrued expenses and other current liabilities
Recognition of Series B preferred stock tranche liability
Extinguishment of Series B preferred stock tranche liability
Merger and related PIPE financing costs included in accounts payable and accrued expenses and other current liabilities
Receivables in transit from issuance of common stock upon exercise of stock options
Unpaid Issuance Costs

Comments